Variable | Began trial on eculizumab (n = 219) | Began trial on ravulizumab (n = 222) | General population (n = 15,386) | |||
---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | |
Age | 47.38 | 15.30 | 45.67 | 14.83 | 53.57 | 15.375 |
Years Since Diagnosis | 8.93 | 8.84 | 9.33 | 8.70 | NA | Â |
Baseline BMI (kg/m2) | 25.25 | 4.23 | 24.83 | 4.71 | Â | Â |
 | # | % | # | % | # | % |
---|---|---|---|---|---|---|
Region | Â | Â | Â | Â | Â | Â |
 Europe | 113 | 51.60 | 106 | 47.75 | 13,373 | 86.92 |
 Japan | 22 | 10.05 | 25 | 11.26 | 0 | 0.00 |
 Latin America | 13 | 5.94 | 9 | 4.05 | 0 | 0.00 |
 North America | 16 | 7.31 | 17 | 7.66 | 2013 | 13.08 |
 Rest of Asia  Pacific | 55 | 25.11 | 65 | 29.28 | 0 | 0.00 |
Female | 102 | 46.58 | 107 | 48.20 | 7650 | 49.72 |